DIRECT ORAL ANTICOAGULANTS AVAILABLE IN THE PHARMACOLOGICAL THERAPEUTICS AND THEIR ANTIDOTES

• At: AbuDhabi (United Arab Emirates) (2019)
• Type: Poster
• Poster code: POS-HPS-106
• By: MORGADO, Manuel (University of Beira Interior, Health Science Faculty, Portugal)
• Co-author(s): Sandra Morgado: Pharmaceutical Services, University Hospital Center of Cova da Beira, Covilhã, Portugal
  Manuel Morgado: Pharmaceutical Services, University Hospital Center of Cova da Beira, Covilhã, Portugal;Health Science Faculty, University of Beira Interior, Covilhã, Portugal
  Marta Mendes: Pharmaceutical Services, University Hospital Center of Cova da Beira, Covilhã, Portugal
  Ema Paulino: Portuguese Pharmaceutical Society, Lisbon, Portugal
  Olímpia Fonseca: Pharmaceutical Services, University Hospital Center of Cova da Beira, Covilhã, Portugal;Health Science Faculty, University of Beira Interior, Covilhã, Portugal
  
• Abstract:

  Background

  Direct oral anticoagulants (DOACs) act by selectively inhibiting only one coagulation factor. These drugs are advantageous because they have a wide therapeutic window and do not require routine monitoring by international normalized ratio (INR).

  Methods

  A literature review was performed, through research of articles obtained from PubMed

  ..

The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress. Please login